INSMED INC (INSM) Debt Components
- 2026-06-30: Long-term Debt, Excluding Current MaturitiesUSD $543.51M; Long-term DebtUSD $546.77M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $341.73M.
- 2026-03-31: Long-term Debt, Excluding Current MaturitiesUSD $542.22M; Long-term DebtUSD $546.77M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $341.73M.
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD $540.96M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Excluding Current MaturitiesUSD (m); Long-term DebtUSD $546.77M; Long-Term Debt, Maturity, Year OneUSD $0.00; Long-Term Debt, Maturity, Year TwoUSD $0.00.
INSMED INC Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Current Maturities USD | Debt, Current USD | Secured Debt USD | Line of Credit Facility, Maximum Borrowing Capacity USD | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Conversion Price USD/shares | Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate pure | Debt Instrument, Unamortized Discount USD | Debt Instrument, Basis Spread on Variable Rate (Deprecated 2013-01-31) pure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $543.51M | $546.77M | $0.00 | $341.73M | $205.04M | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $542.22M | $546.77M | $0.00 | $341.73M | $205.04M | $0.00 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $540.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $546.77M | $0.00 | $0.00 | $341.73M | $205.04M | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $539.72M | $546.77M | $0.00 | $0.00 | $341.73M | $205.04M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $538.51M | $546.77M | $0.00 | $0.00 | $341.73M | $205.04M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $1.11B | $1.12B | $0.00 | $0.00 | $916.65M | $205.04M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.10B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.12B | $0.00 | $0.00 | $0.00 | $916.65M | $205.04M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $954.83M | $971.76M | $0.00 | $198.38M | $198.38M | $574.99M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $946.83M | $1.19B | $0.00 | $195.05M | $195.05M | $575.00M | (m) | (m) | $225.00M | $224.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $939.08M | $1.18B | $225.00M | $191.89M | $191.89M | $575.00M | (m) | (m) | $0.00 | $224.19M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $1.16B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $1.18B | $0.00 | $225.00M | $188.77M | $188.77M | $575.00M | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.15B | $1.17B | $0.00 | $225.00M | $185.68M | $185.68M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.14B | $1.17B | $0.00 | $225.00M | $182.68M | $182.68M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.13B | $1.16B | $0.00 | $225.00M | $179.81M | $179.81M | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.13B | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $1.15B | $0.00 | $0.00 | $225.00M | $177.08M | $177.08M | $575.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $784.80M | $800.00M | $0.00 | $0.00 | $225.00M | $0.00 | (m) | (m) | $0.00 | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-06-30 | $783.98M | $800.00M | $0.00 | $0.00 | $225.00M | $0.00 | (m) | (m) | $0.00 | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2022-03-31 | $783.16M | $800.00M | $0.00 | $0.00 | $225.00M | $0.00 | (m) | (m) | $0.00 | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $0.00 | (m) |
| 2021-12-31 | $566.59M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $221.87M | (m) |
| 2021-12-31 | (m) | $800.00M | $0.00 | $0.00 | $0.00 | $225.00M | $0.00 | $575.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $557.60M | $800.00M | $0.00 | $0.00 | $0.00 | $225.00M | (m) | (m) | $0.00 | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $230.32M | (m) |
| 2021-06-30 | $548.75M | $800.00M | $0.00 | $0.00 | $0.00 | $225.00M | (m) | (m) | $0.00 | (m) | (m) | $800.00M | (m) | (m) | (m) | (m) | $238.63M | (m) |
| 2021-03-31 | $361.57M | $450.00M | $0.00 | $0.00 | $0.00 | $450.00M | (m) | (m) | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $83.13M | (m) |
| 2020-12-31 | $356.32M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $88.04M | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $450.00M | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $351.13M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $92.88M | (m) |
| 2020-06-30 | $346.00M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $97.65M | (m) |
| 2020-03-31 | $340.94M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $102.37M | (m) |
| 2019-12-31 | $335.94M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $107.02M | (m) |
| 2019-12-31 | (m) | $450.00M | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $331.00M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $111.61M | (m) |
| 2019-06-30 | $326.13M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $116.13M | (m) |
| 2019-03-31 | $321.31M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $120.60M | (m) |
| 2018-12-31 | $316.56M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $125.00M | (m) |
| 2018-12-31 | (m) | $450.00M | $0.00 | $0.00 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $311.86M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $129.35M | (m) |
| 2018-06-30 | $307.16M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $133.64M | (m) |
| 2018-03-31 | $302.71M | $450.00M | (m) | $0.00 | $0.00 | $0.00 | $0.00 | $450.00M | $0.00 | (m) | (m) | $450.00M | (m) | (m) | (m) | (m) | $137.87M | (m) |
| 2017-12-31 | $55.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $55.00M | $0.00 | $13.40M | $41.60M | (m) | (m) | (m) | (m) | $0.00 | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $55.39M | $55.00M | (m) | $0.00 | $13.40M | $41.60M | (m) | (m) | $0.00 | (m) | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $55.19M | $55.00M | (m) | $3.27M | $20.75M | $30.98M | (m) | (m) | (m) | (m) | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $54.99M | $55.00M | (m) | $3.27M | $20.75M | $30.98M | (m) | (m) | (m) | (m) | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $54.79M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $55.00M | (m) | $3.27M | $20.75M | $30.98M | (m) | (m) | (m) | (m) | (m) | $55.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $34.68M | $35.00M | (m) | (m) | $8.53M | $13.84M | $12.64M | (m) | (m) | (m) | (m) | $35.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $16.14M | $25.00M | (m) | $12.18M | $9.95M | (m) | (m) | (m) | $2.87M | $8.69M | $8.69M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $19.11M | $25.00M | (m) | $12.18M | $9.95M | (m) | (m) | (m) | $2.87M | $5.67M | $5.67M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $22.03M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $25.00M | $2.87M | $12.18M | $9.95M | (m) | (m) | (m) | (m) | (m) | $3.11M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $25.00M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | $25.26M | $25.26M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $25.00M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | $25.12M | $25.12M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $25.00M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | $24.99M | $24.99M | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $24.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $25.00M | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $25.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $14.71M | $20.00M | (m) | $7.43M | $12.57M | (m) | (m) | (m) | (m) | $5.18M | $5.18M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $16.49M | $20.00M | (m) | $7.43M | $12.57M | (m) | (m) | (m) | (m) | $3.28M | $3.28M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $14.57M | $20.00M | (m) | $7.79M | $8.59M | (m) | (m) | (m) | $3.63M | $5.19M | $5.19M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $16.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.28M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | $20.00M | $3.63M | $7.79M | $8.59M | (m) | (m) | (m) | (m) | (m) | $3.28M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $12.54M | $20.00M | (m) | $9.52M | $10.45M | $30.00K | (m) | (m) | (m) | $7.05M | $-7.05M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $14.89M | $20.00M | (m) | $9.52M | $10.45M | $30.00K | (m) | (m) | (m) | $4.65M | $-4.65M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $14.51M | $20.00M | (m) | $7.72M | $8.48M | $788.00K | (m) | (m) | $3.01M | $4.88M | $-4.88M | $20.00M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $16.22M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $3.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $20.00M | $3.01M | $7.72M | $8.48M | $788.00K | (m) | (m) | (m) | (m) | $-3.01M | $20.00M | (m) | (m) | (m) | 9.25% | $194.00K | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $8.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $592.00K | $10.00M | $20.00M | (m) | (m) | 9.25% | $220.00K | 4.50% |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $8.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $10.00M | $20.00M | (m) | (m) | 9.25% | $-245.00K | 4.50% |
| 2012-06-29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $20.00M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $9.20M | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1.00 | (m) | (m) | (m) |
| 2011-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $-9.18M | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $-9.18M | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $-9.18M | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $0.00 | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |